32
Participants
Start Date
January 31, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Inosine
Twenty-five eligible subjects will receive inosine for 12 weeks (administered in the form of 500 mg capsules, 1 to 6 capsules a day for a total daily dose of up to 3 gm). The dose of inosine will be titrated to target urate levels of 7-8 mg/dL based on urate level measurement that will occur at Week 2, Week 4, Week 6, and Week 9 after Baseline.
Massachusetts General Hospital, Boston
The Salah Foundation
OTHER
Sean M. Healey & AMG Center for ALS
OTHER
Massachusetts General Hospital
OTHER